Transcription of FLUZONE Quadrivalent
{{id}} {{{paragraph}}}
Sanofi Pasteur Product Monograph 450/477 - FLUZONE Quadrivalent Page 1 of 35 PRODUCT MONOGRAPH FLUZONE Quadrivalent Influenza Virus Vaccine Quadrivalent Types A and B (Split Virion) Suspension for injection Active Immunizing Agent for the Prevention of Influenza ATC Code: J07B B Manufactured by: Sanofi Pasteur Limited Toronto, Ontario, Canada Fabricated by: Sanofi Pasteur Inc. Swiftwater, PA 18370 USA Control #: 238593 Date of Approval: April 29, 2020 Sanofi Pasteur Product Monograph 450/477 - FLUZONE Quadrivalent Page 2 of 35 Table of Contents PART I: health PROFESSIONAL INFORMATION .. 4 SUMMARY PRODUCT INFORMATION .. 4 DESCRIPTION .. 4 INDICATIONS AND CLINICAL USE .. 4 CONTRAINDICATIONS .. 5 WARNINGS AND PRECAUTIONS .. 5 General .. 5 Hematologic .. 6 Immune .. 6 Neurologic .. 6 Special Populations .. 7 ADVERSE REACTIONS .. 7 Adverse Drug Reaction Overview.
current requirements of the World Health Organization (WHO). (1) The strains for the 2020-2021 ... therapy, intramuscular injections with FLUZONE ... NACI states that influenza vaccination is considered safe for breastfeeding women. Pediatrics
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}